[{"id":"c7e9b9c9-d4ce-4d93-91cb-690df0a318f7","acronym":"Delivir","url":"https://clinicaltrials.gov/study/NCT05788926","created_at":"2023-03-29T14:03:17.793Z","updated_at":"2024-07-02T16:35:32.334Z","phase":"Phase 1","brief_title":"A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)","source_id_and_acronym":"NCT05788926 - Delivir","lead_sponsor":"Transgene","biomarkers":" EGFR • HER-2 • PD-L1 • KRAS • ALK • RET • ROS1","pipe":" | ","alterations":" BRAF V600E • KRAS mutation • KRAS G12C • BRAF V600 • HER-2 mutation • RET fusion • RET mutation • ROS1 fusion • RET rearrangement • KRAS G12","tags":["EGFR • HER-2 • PD-L1 • KRAS • ALK • RET • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF V600E • KRAS mutation • KRAS G12C • BRAF V600 • HER-2 mutation • RET fusion • RET mutation • ROS1 fusion • RET rearrangement • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TG6050"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 04/05/2023","start_date":" 04/05/2023","primary_txt":" Primary completion: 10/30/2024","primary_completion_date":" 10/30/2024","study_txt":" Completion: 03/31/2025","study_completion_date":" 03/31/2025","last_update_posted":"2023-10-20"}]